What it measures.
C-peptide is released in equal amounts with insulin from pancreatic beta cells. Unlike insulin (which is rapidly cleared by the liver), C-peptide circulates longer and isn't affected by injected insulin, making it an accurate measure of endogenous insulin production.
C-peptide (connecting peptide) is cleaved from proinsulin when insulin is produced and released in a 1:1 ratio with insulin. It measures how much insulin your pancreas is actually making, unaffected by external insulin or liver clearance.
Why it matters.
C-peptide distinguishes between insulin resistance (high C-peptide) and insulin deficiency (low C-peptide). It's essential for classifying diabetes type, monitoring beta-cell function, and evaluating hypoglycemia in patients on insulin therapy.
Physiology.
In pancreatic beta cells, proinsulin is cleaved into insulin and C-peptide before release. While insulin is rapidly extracted by the liver (about 50% on first pass), C-peptide circulates with a longer half-life. This makes C-peptide a more stable indicator of total insulin secretion.
Testing & preparation.
How to prepare
- Fast for 8-12 hours
- No special preparation otherwise
- Can be measured random or stimulated for specific purposes
When to test
When differentiating diabetes types, evaluating unexplained hypoglycemia, or monitoring beta-cell function in patients on insulin therapy.
How often
Not routine screening; ordered for specific diagnostic purposes.
Interpretation.
High c-peptide
Common causes:
- Insulin resistance with compensatory overproduction
- Early type 2 diabetes
- Insulinoma (rare)
- Obesity
- Kidney disease (reduced clearance)
Implications:
- Beta cells are working hard to compensate
- Insulin resistance is likely
- Risk of eventual beta-cell exhaustion
Low c-peptide
Common causes:
- Type 1 diabetes
- Advanced type 2 diabetes (beta-cell failure)
- Pancreatectomy
- Long-term insulin therapy causing beta-cell atrophy
- MODY (some forms)
Implications:
- Insufficient endogenous insulin production
- May require insulin therapy
- Indicates significant beta-cell dysfunction
Optimization.
Diet
- High C-peptide: reduce carbohydrate intake to lower insulin demand
- Low C-peptide: dietary management of diabetes while on insulin
Lifestyle
- Weight loss can improve beta-cell function in type 2 diabetes
- Exercise improves insulin sensitivity, reducing demand on beta cells
Supplements
- No supplements directly improve beta-cell function
FAQs.
Why test C-peptide instead of insulin?
C-peptide is preferred when: (1) the patient is on insulin therapy (injected insulin won't affect C-peptide), (2) more stable measurement is needed (longer half-life), or (3) distinguishing between insulin resistance and deficiency.
What does low C-peptide mean?
Low C-peptide indicates your pancreas isn't making much insulin. This is characteristic of type 1 diabetes (autoimmune destruction of beta cells) or advanced type 2 diabetes (beta-cell exhaustion). It typically means insulin therapy will be needed.
Can C-peptide be too high?
Yes. High C-peptide indicates insulin overproduction, usually from insulin resistance. The pancreas is working overtime to keep glucose controlled. This is common in obesity and early type 2 diabetes. Rarely, high C-peptide suggests insulinoma (insulin-producing tumor).
Does C-peptide change over time in diabetes?
Yes. In type 2 diabetes, C-peptide is often initially high (compensatory hyperinsulinemia) but may decline over years as beta cells become exhausted. Monitoring C-peptide can help predict when insulin therapy might become necessary.